SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan.

about

SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan.

Item

http://www.wikidata.org/entity/Q38824557

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan.

@en

type

Item

label

SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan.

@en

prefLabel

SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan.

@en

P1476

SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan

@en

P2093

Mariko Abe

http://www.w3.org/2001/XMLSchema#string

Masahiro Shinozaki

http://www.w3.org/2001/XMLSchema#string

Shinya Nishio

http://www.w3.org/2001/XMLSchema#string

P2860

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group compar

The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study

Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

P304

2073-2084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1232395

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroyuki Ito

P577

2016-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27592508

http://www.w3.org/2001/XMLSchema#string